Coccidioidomycosis in patients infected with human immunodeficiency virus: Review of 91 cases at a single institution

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 563-568

  Singh, Vipul R ^a   Smith, Deborah K ^a   Lawerence, James ^a   Kelly, Peter C ^a   Thomas, Allen R ^a   Spitz, Bradley ^a   Sarosi, George A ^a  

^a MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE;

ADULT; ARTICLE; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL; THORAX RADIOGRAPHY;

EID: 0029829111     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.563     Document Type: Article

References (18)

1. Drutz DJ, Catanzaro A. Coccidioidomycosis. Parts I and II. Am Rev Respir Dis 1978;117:559-85, 727-71.
2. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988;2:199-238.
3. Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN. Symptoms and routine laboratory abnormalities associated with Coccidioidomycosis. West 1 Med 1988;149:419-21.
4. Ampel NM, Wieden MA, Galgiani JN. Coccidioidomycosis: clinical update. Rev Infect Dis 1989;11:897-911.
5. Beaman L, Pappagianis D, Benjamin E. Mechanisms of resistance to infection with Coccidioides immitis in mice. Infect Immun 1979;23:681-5.
6. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts: experience at Stanford University Hospital. Medicine (Baltimore) 1975;54:377-95.
7. Antoniskis D, Larsen RA, Akil B, Rarick MU, Leedom JM. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS 1990;4:691-3.
8. Bronnimann DA, Adam RD, Galgiani JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:372-9.
9. Kovacs A, Forthal DN, Kovacs JA, Overturf GD. Disseminated coccidioidomycosis in a patient with acquired immune deficiency syndrome. West J Med 1984;140:447-9.
10. Wolf JE, Linie JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis 1986;5:331-6.
11. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine (Baltimore) 1990;69:384-91.
12. Rutala PJ, Smith JW. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci 1978;275:283-95.
13. Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis: an analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore). 1986;65:312-21.
14. Ampel NM, Dois CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993;94:235-240.
15. Smith CE, Saito MT, Simons SA. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 1956;160:546-52.
16. Spitz BL, Thomas AR, Kelly PC, Sarosi GA. Coccidioidomycosis (CI) in HIV infected patients [abstract]. Am Rev Respir Dis 1991;143(4 pt 2)(suppl):A720.
17. McNeil MM, Ampel NM. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995;21(suppl 1):S111-3.
18. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 1993;119:28-35.